Aurora Cannabis (ACB) Operating Leases (2019 - 2026)
Aurora Cannabis (ACB) posted quarterly Operating Leases of $13.2 million for Q1 2026, down 49.41% year-on-year from $26.1 million in Q1 2025, and down 44.47% on a QoQ basis from $23.8 million in Q4 2025.
Aurora Cannabis (ACB) Operating Leases (2019 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Operating Leases for 8 consecutive years, with $13.2 million the latest figure, recorded in Q1 2026.
- Quarterly Operating Leases fell 49.41% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (down 49.41% YoY) and the FY2026 annual result came in at $13.1 million, down 51.36% from the prior year.
- Operating Leases eased to $13.2 million in Q1 2026 per ACB's latest filing, from $23.8 million in the prior quarter.
- Over the last five years, Operating Leases for ACB reached as high as $50.6 million in Q3 2023 and fell as low as $13.2 million in Q1 2026.
- A 5-year average of $35.3 million and a median of $35.3 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases soared 86.56% — and 2026, when it tumbled 49.41%.
- Year by year, Operating Leases stood at $33.2 million in 2022, then surged by 46.11% to $48.5 million in 2023, then decreased by 11.11% to $43.1 million in 2024, then tumbled by 44.73% to $23.8 million in 2025, then slumped by 44.47% to $13.2 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $13.2 million, $23.8 million, and $25.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.22 Mn |
| Dec 31, 2025 | 23.81 Mn |
| Sep 30, 2025 | 25.43 Mn |
| Jun 30, 2025 | 26.20 Mn |
| Mar 31, 2025 | 26.13 Mn |
| Dec 31, 2024 | 43.08 Mn |
| Sep 30, 2024 | 43.46 Mn |
| Jun 30, 2024 | 49.72 Mn |
| Mar 31, 2024 | 35.27 Mn |
| Dec 31, 2023 | 48.46 Mn |
| Sep 30, 2023 | 50.60 Mn |
| Jun 30, 2023 | 46.73 Mn |
| Mar 31, 2023 | 36.41 Mn |
| Dec 31, 2022 | 33.17 Mn |
| Sep 30, 2022 | 27.12 Mn |
| Jun 30, 2022 | 33.72 Mn |
| Mar 31, 2022 | 37.65 Mn |
| Dec 31, 2021 | 47.15 Mn |
| Sep 30, 2021 | 48.44 Mn |
| Jun 30, 2021 | 58.26 Mn |